Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
This study is the first and largest secondary prevention trial about lipid-lowering therapy
for acute ischemic stroke patients at high-risk of intracranial hemorrhage.
The primary hypothesis of this study is: excessive reduction in serum lipid levels by
intensive statin therapy in acute ischemic stroke patients with cerebral microbleeds can
increase the risk of intracranial hemorrhage.
This study will shed light on new clinical decisions regarding the long-term serum lipid
management in these patients with dilemma in clinical practice.
Phase:
Phase 4
Details
Lead Sponsor:
Sichuan Provincial People's Hospital
Collaborator:
Science & Technology Department of Sichuan Province